Summary: Creative Biolabs is a leader and explorer in novel therapeutics development. With our Ph.D. level scientists and extensive experience in antibody-drug conjugate (ADC) chemistry, Creative Biolabs now provides our customers with elaborated analysis services for the complete assessment of the drug to antibody ratio (DAR) and drug load distribution of an ADC. Creative Biolabs integrates multiple analytical platforms to provide customers with comprehensive assessments for the drug to antibody ratio (DAR) and drug load distribution of an ADC. https://www.creative-biolabs.com/adc/dar-and-payload-distribution-analysis.htm